XML 23 R46.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock-Based Compensation - Additional Information (Detail) (USD $)
12 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2010
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Options granted and outstanding to purchase 1,910,794 729,096 812,334
Options granted 1,229,500 20,000  
Stock-based compensation expense $ 1,241,404 $ 1,376,921  
Stock-based compensation expense in discontinued operations 0 27,519  
Fair value of the options granted 4,091,117 93,004  
Intrinsic value of the options exercised 0 3,666  
Arrowhead [Member]
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Pre-tax compensation expense 3,738,217    
Weighted average period to recognize pre-tax compensation expense 3 years 1 month 6 days    
Calando Pharmaceuticals, Inc. [Member]
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Fair value of the options granted 33,690 33,870  
Pre-tax compensation expense $ 63,250    
Weighted average period to recognize pre-tax compensation expense 2 years 7 months 6 days    
2000 Stock Option Plan [Member]
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Shares reserve for issuance 153,200    
Options granted and outstanding to purchase 153,200    
2004 Equity Incentive Plan [Member]
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Shares reserve for issuance 1,965,860    
Options granted and outstanding to purchase 1,767,894    
Options granted 988,300    
Options granted outside of Equity Incentive plans 251,200